Progressive supranuclear palsy is a rare brain disease that poses significant challenges for patients and their families. While there is currently no cure, treatments can help manage symptoms and improve quality of life. Understanding the available therapies—from standard medications to promising clinical trial drugs—empowers patients to work with their healthcare teams toward better care.

Understanding How Treatment Helps Manage This Complex Brain Condition

Progressive supranuclear palsy, often referred to as PSP, is a rare neurological disorder that requires a thoughtful approach to treatment. The main goal of therapy is not to cure the disease, which currently remains impossible, but rather to ease symptoms, slow down the progression where feasible, and maintain the best possible quality of life for as long as possible.^[1][2]

Treatment strategies depend on many factors, including the stage of the disease, which symptoms are most troublesome, and the overall health of the person affected. Because PSP causes problems in multiple areas—balance, eye movement, swallowing, thinking, and mood—a comprehensive approach is needed.^[3] Standard treatments that are already approved by medical societies form the foundation of care, but researchers are also working hard to develop new therapies. These experimental drugs are being tested in clinical trials across the United States and other countries, offering hope for better options in the future.^[11]

One important thing to understand is that PSP is not the same as Parkinson’s disease, even though some symptoms overlap. This means that medications used for Parkinson’s may not work as well for PSP, and the disease often progresses more quickly.^[4][5] Still, doctors and specialists use a combination of medications, physical support, and lifestyle adjustments to help patients live better with this condition.

Standard Treatment Methods Used Today

Currently, there is no medication specifically designed to treat progressive supranuclear palsy. Instead, doctors rely on drugs that are commonly used for similar movement disorders, especially Parkinson’s disease, and adapt them to the needs of PSP patients.^[8] The most commonly tried medication is levodopa, which is often combined with another substance called carbidopa. Together, these drugs are known as Sinemet. Levodopa helps increase levels of a brain chemical called dopamine, which is involved in controlling smooth and coordinated muscle movements.^[9][15]

The response to levodopa in PSP patients varies widely. Some people experience mild improvement in muscle stiffness and slowness of movement, especially early in the disease. However, the benefit is often limited and temporary, usually lasting only about two to three years in most patients.^[8][18] Higher doses of levodopa do not necessarily provide better results and can instead cause side effects such as nausea, dizziness, or involuntary movements. For this reason, doctors carefully monitor patients and adjust doses based on individual response.

Beyond levodopa, other medications are used to target specific symptoms. Antidepressants are commonly prescribed because depression, apathy, and irritability are frequent in PSP.^[8][9] These medications can also help with pain, bladder and bowel problems, and disturbed sleep, which are often part of the disease experience. If muscle stiffness or rigidity becomes severe, doctors may prescribe muscle relaxants to ease discomfort.^[15]

For patients who experience troublesome eyelid spasms or have difficulty opening their eyes, injections of botulinum toxin (commonly known as Botox) can be very helpful.^[8][9] Botox works by blocking the signals from the brain to the affected muscles, which helps relax them. The effects typically last for about three months, after which the injections need to be repeated.

In addition to medications, non-drug therapies play a critical role in managing PSP. Physiotherapy helps patients maintain mobility, improve posture, and reduce the risk of falls.^[9] Physical therapists can teach exercises to strengthen muscles and improve balance, and they can recommend assistive devices such as walking frames or specially designed shoes to prevent slipping. Breathing exercises taught by physiotherapists can also help reduce the risk of aspiration pneumonia, a serious complication where food particles fall into the lungs.^[9]

Speech and language therapy is equally important, especially as the disease affects speech clarity and swallowing ability.^[9] Therapists can teach techniques to make speech clearer and advise on communication aids if needed. They also provide guidance on swallowing techniques and may recommend changes to the texture or consistency of food to make swallowing safer and easier. In severe cases where swallowing becomes very difficult, a feeding tube may be necessary to prevent malnutrition and dehydration.^[9][15]

Occupational therapy focuses on helping patients remain as independent as possible in daily activities such as washing, dressing, and eating.^[9] Occupational therapists assess the home environment for safety hazards that could lead to falls, such as poor lighting, loose rugs, or cluttered walkways. They can suggest modifications and equipment to improve safety and ease of movement.

For eye-related problems, such as difficulty controlling eyelids or sensitivity to bright light, special glasses with prisms or weighted tools to aid walking may be recommended.^[9][13] Some patients find relief by wearing sunglasses indoors to reduce light sensitivity.

The duration of treatment is ongoing and lifelong, as PSP is a progressive condition. Regular follow-up appointments are essential to monitor symptoms, adjust medications, and coordinate care among different healthcare professionals. Most patients are cared for by a multidisciplinary team, which includes neurologists, physiotherapists, speech therapists, occupational therapists, dietitians, and social workers.^[9] This team approach ensures that all aspects of the patient’s health and well-being are addressed.

Promising Therapies Being Tested in Clinical Trials

While standard treatments provide some relief, researchers are actively working to develop new drugs that could more effectively slow down or halt the progression of PSP. These experimental therapies are being tested in clinical trials, which are carefully controlled studies designed to evaluate the safety and effectiveness of new treatments.^[11]

One of the most exciting developments in PSP research is a large clinical trial funded by the National Institute on Aging in the United States. This trial, led by researchers at the University of California, San Francisco, has received up to $75.4 million over five years and represents one of the largest grants for a neurodegenerative disorder in recent years.^[11] The trial will test three drugs at the same time, and if none of them prove effective, additional drugs will be added. The goal is to find treatments that can slow disease progression by 20% to 30%, which would be a meaningful improvement for patients facing a condition with relentless worsening and no cure.

The trial is expected to involve up to 50 sites across the United States, making it accessible to many patients and their families.^[11] The researchers hope that by testing multiple drugs simultaneously, they can accelerate the discovery of effective therapies and transform the type of care that PSP patients receive. Even a modest slowing of disease progression could significantly improve quality of life and extend the time patients remain independent.

PSP is believed to be caused by the buildup of a protein called tau in the brain. Tau is a normal protein that helps maintain the structure of brain cells, but in PSP, it becomes abnormal and forms harmful clumps that damage and kill cells in areas of the brain responsible for movement, coordination, and thinking.^[2][7] Many of the experimental therapies in clinical trials are designed to target tau in various ways—by reducing its production, preventing it from clumping together, or helping the body clear it away more effectively.

One drug that was previously tested in clinical trials is davunetide.^[15] Although this particular drug did not prove successful in later-stage trials, it provided valuable information that helped researchers refine their approach to developing new treatments. Learning from past trials is an essential part of the research process, and each study brings scientists closer to finding effective therapies.

Clinical trials for PSP typically follow a staged process. In Phase I trials, researchers focus on testing the safety of a new drug in a small group of participants. They want to understand whether the drug causes harmful side effects and determine the appropriate dose.^[11] If the drug is found to be safe, it moves to Phase II trials, which involve more participants and focus on evaluating whether the drug actually works—does it improve symptoms or slow disease progression? Finally, Phase III trials compare the new drug to the current standard treatment or a placebo (an inactive substance) in a large group of patients to confirm its effectiveness and monitor for side effects.

Participating in a clinical trial can offer several benefits. Patients gain access to cutting-edge therapies that are not yet available to the general public. They also receive close monitoring and care from a team of specialists. However, clinical trials also involve uncertainty—the experimental treatment may not work, or it may cause unexpected side effects. Patients considering participation should discuss the potential risks and benefits with their healthcare team and family members.

Researchers are also exploring therapies that go beyond targeting tau. Some studies are investigating drugs that address inflammation in the brain, which may contribute to the damage seen in PSP. Others are looking at ways to protect brain cells from dying or to improve their function. These approaches are based on a growing understanding of the complex biological processes that underlie PSP.

The location of clinical trials varies, but many are conducted in the United States, Europe, and other regions with advanced medical research infrastructure. Patients interested in participating should check trial databases or consult with their healthcare providers to find studies that are recruiting participants. Some trials may cover travel expenses or provide other forms of support to participants.

While the path to effective treatments for PSP is challenging, the pace of research is accelerating. Advances in imaging technology, genetic studies, and our understanding of tau biology are opening new doors. The large-scale trial funded by the National Institute on Aging is a testament to the commitment of the scientific community to finding solutions for PSP patients.^[11] Researchers hope that within the next several years, at least one or more of the experimental therapies will prove successful and become available as a standard treatment option.

Most Common Treatment Methods

• Medication for Movement Symptoms
  • Levodopa combined with carbidopa (Sinemet) to improve muscle stiffness and slowness, though the effect is often limited and temporary.^[8][18]
  • Muscle relaxants for severe stiffness or rigidity.^[15]
• Medication for Mood and Behavioral Symptoms
  • Antidepressants to help with depression, irritability, apathy, and other emotional symptoms, as well as pain, bladder issues, and sleep disturbances.^[8][9]
• Botulinum Toxin Injections (Botox)
  • Injections into muscles around the eyes to relieve eyelid spasms and help with difficulty opening the eyes.^[8][9]
  • Effects last about three months and require repeated injections.
• Physiotherapy
  • Exercises to strengthen muscles, improve balance, and maintain mobility.^[9]
  • Recommendations for assistive devices like walking frames and specially designed shoes to prevent falls.
  • Breathing exercises to reduce the risk of aspiration pneumonia.
• Speech and Language Therapy
  • Techniques to improve speech clarity and communication.^[9]
  • Guidance on swallowing techniques and dietary modifications to make eating safer.
  • Advice on communication aids as the disease progresses.
• Occupational Therapy
  • Assistance with daily activities such as washing, dressing, and eating to maintain independence.^[9]
  • Home safety assessments to identify and address fall hazards like poor lighting or loose rugs.
• Nutritional Support
  • Dietitian advice on maintaining a healthy, balanced diet with appropriate food textures for safe swallowing.^[9]
  • Feeding tubes (such as a PEG tube) in advanced cases where swallowing becomes too difficult and the risk of malnutrition is high.^[9][15]
• Vision and Eye Care
  • Special glasses with prisms to improve vision difficulties.^[13]
  • Sunglasses to manage sensitivity to bright light (photophobia).^[9]
• Experimental Therapies in Clinical Trials
  • Large-scale clinical trials testing multiple drugs simultaneously, aiming to slow disease progression by targeting tau protein and other mechanisms.^[11]
  • Trials conducted at up to 50 sites across the United States, with ongoing research in Europe and other regions.
  • Potential benefits include access to cutting-edge therapies and close monitoring by specialist teams.